Clinical Activity of Pembrolizumab in a Patient With Metastatic Triple-Negative Breast Cancer Without Tumor Programmed Death-Ligand 1 Expression: A Case Report and Correlative Biomarker Analysis.
暂无分享，去创建一个
A. Godwin | O. Tawfik | R. Jensen | R. Seitz | Q. Khan | P. Sharma | A. O’Dea | Fang-tian Fan | R. Ash | D. Hout | D. Bailey | Jaimie Heldstab | Sajjad A. Bhatti | Priyanka Sharma | C. Lehn | S. Bhatti